Medical Condition News

RSS

Study compares very low-carbohydrate vs DASH diets for obese adults with hypertension and diabetes

Adults with hypertension, prediabetes, or type 2 diabetes, and who are overweight or obese, are at an increased risk of serious health complications.

24 May 2023

Focusing on satiety and satiation may be better for weight loss success

Researchers hypothesized that focusing on satiety (feeling free of hunger) and satiation (feeling satisfied with a meal) through the consumption of fruits and vegetables may be better targets for weight loss success.

24 May 2023

Investigating the interplay between white blood cell count and incidence of hyper-low-density lipoprotein cholesterolemia

Researchers investigating the association between white blood cell count and LDL hypercholesteremia.

24 May 2023

Is COVID-19 diagnosis associated with the risk and incidence of type 1 diabetes?

Researchers assessed the incidence and risk of type 1 diabetes in children with coronavirus disease 2019.

24 May 2023

What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?

Researchers assessed the safety and efficacy of danuglipron in type 2 diabetes (T2D) patients.

24 May 2023

Rural patients have worse diabetic quality metrics than urban counterparts

Mayo Clinic researchers conducted a study within their health care system to identify factors associated with quality of care among rural and urban patients with diabetes.

24 May 2023

Gut bacteria toxins: A hidden trigger for Parkinson's disease?

Gut dysfunction and the presence of lipopolysaccharide (LPS) endotoxins contribute to the pathogenesis of Parkinson's disease (PD), leading to neuroinflammation and neurodegeneration. Modulating the gut microbiome and reducing LPS levels may hold potential as treatment strategies for PD.

24 May 2023

New tests based on biomarkers may improve diagnosis and treatment of acute kidney injury

Hospital inpatients who develop an acute kidney injury (AKI) generally fare poorly after being discharged, and have few options for effective treatment.

24 May 2023

Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients

Research investigates the effectiveness of oral antiviral medications, Molnupiravir and Nirmatrelvir-Ritonavir, in treating patients with type 2 diabetes and mild to moderate COVID-19. The study aims to determine the efficacy of these medications in reducing adverse outcomes in this specific population.

24 May 2023

Unraveling the Epstein-Barr virus enigma: The puzzling role in multiple sclerosis development

Epstein-Barr virus (EBV) has a significant role in the development of multiple sclerosis (MS), with evidence linking EBV infection to increased MS risk and immune dysregulation. Understanding the mechanisms underlying this connection is crucial for advancing MS therapies and prevention strategies.

24 May 2023

Hypnotic drug class may not have increased the risk of exacerbations and death among COPD patients

Chronic obstructive pulmonary disease patients newly prescribed non-benzodiazepine benzodiazepine receptor agonists (NBZRAs) such as zolpidem (Ambien, Intermezzo and other brands), a class of hypnotic drugs prescribed for insomnia, did not have an increased risk of exacerbations requiring hospitalizations or of death than those prescribed other types of hypnotics, according to research published at the ATS 2023 International Conference.

24 May 2023

Processed danger: Industrial food additives and the health risks to children

Researchers explore the potential negative health effects on children due to the use of industrial additives in processing.

23 May 2023

Cannabis use, emotions, and mental health: Unraveling the young adult connection

Emotion dysregulation mediates the association between cannabis use and mental health in young adults, with sex-dependent effects observed in female users. Interventions targeting emotion dysregulation are crucial for improving mental health outcomes in female, young adult cannabis users.

23 May 2023

Reseachers use CT scans to track the progression of emphysema over time

Researchers at National Jewish Health evaluating computerized tomography (CT) scans of emphysema progression in the COPDGene® study showed that, during a span of 10 years, participants with pre-existing emphysema who continued smoking had the largest decline in adjusted lung density (ALD).

23 May 2023

Transcatheter edge-to-edge procedure to repair leaky mitral valves found to be safe and effective

Long-awaited outcomes data of transcatheter edge-to-edge procedures to repair patients' leaky mitral valves revealed the minimally invasive procedure to be safe and effective in nearly 90% of patients, according to Cedars-Sinai physician-scientists.

23 May 2023

Magnetic stimulation treats depression by reversing the direction of abnormal brain signals

Powerful magnetic pulses applied to the scalp to stimulate the brain can bring fast relief to many severely depressed patients for whom standard treatments have failed.

23 May 2023

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

A bionic pancreas - a wearable, pocket-sized, automated insulin delivery device - that was first developed in a Boston University lab has been cleared by the US Food and Drug Administration (FDA). The iLet Bionic Pancreas is now commercially available, bringing fresh hope to the almost two million Americans with type 1 diabetes.

23 May 2023

New intervention program can help reduce opioid use for chronic pain

Researchers at the University of Warwick and The James Cook University Hospital, Middlesbrough have led a clinical trial, funded by the National Institute for Health and Care Research (NIHR), on a new treatment which can help people stop needing to use opioid painkillers to manage chronic pain.

23 May 2023

AI-POD project poised to revolutionize the prediction and treatment of obesity-related CVDs

Over the course of four years, experts from various fields, including radiology, computational imaging research and industry, will collaborate to develop a state-of-the-art imaging-based AI risk score, a clinical decision support system (CDSS), and a mobile app for personalized risk assessment and prediction of obesity-related CVDs and their associated complications.

23 May 2023

Advances in automated insulin delivery systems reduce disease management burden for patients with diabetes

Type 1 diabetes affects 46.3 million people worldwide, and the number of people affected increases by about 3% each year.

23 May 2023

Medical Condition News

Study compares very low-carbohydrate vs DASH diets for obese adults with hypertension and diabetes

Focusing on satiety and satiation may be better for weight loss success

Investigating the interplay between white blood cell count and incidence of hyper-low-density lipoprotein cholesterolemia

Is COVID-19 diagnosis associated with the risk and incidence of type 1 diabetes?

What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?

Rural patients have worse diabetic quality metrics than urban counterparts

Gut bacteria toxins: A hidden trigger for Parkinson's disease?

New tests based on biomarkers may improve diagnosis and treatment of acute kidney injury

Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients

Unraveling the Epstein-Barr virus enigma: The puzzling role in multiple sclerosis development

Hypnotic drug class may not have increased the risk of exacerbations and death among COPD patients

Processed danger: Industrial food additives and the health risks to children

Cannabis use, emotions, and mental health: Unraveling the young adult connection

Reseachers use CT scans to track the progression of emphysema over time

Transcatheter edge-to-edge procedure to repair leaky mitral valves found to be safe and effective

Magnetic stimulation treats depression by reversing the direction of abnormal brain signals

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

New intervention program can help reduce opioid use for chronic pain

AI-POD project poised to revolutionize the prediction and treatment of obesity-related CVDs

Advances in automated insulin delivery systems reduce disease management burden for patients with diabetes

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News